📈 Markets & Finance
Live
These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead
Written by Prosper Junior Bakiny for The Motley Fool -> Moderna is racing towards important clinical and regulatory catalysts. Krystal Biotech still has a large market to address in its core area. …
Nasdaq News — 17 June 2026
Text:
6
0
0
Moderna is racing towards important clinical and regulatory catalysts. Krystal Biotech still has a large market to address in its core area. Despite
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
Sam Altman says OpenAI's top token spender uses 100 billion tokens a month — and they're not even the world leader
📈 Markets & Finance
Intel, AMD, Micron shares sink as Broadcom results spark semiconductor sector sell-off
📈 Markets & Finance
This Smart‑Money Legend Won Big on Intel. The Rest of His Portfolio Might Be Even More Revealing
📈 Markets & Finance
A new NJ bill would hand pet owners up to $900 in tax credits — and your state could be next
📈 Markets & Finance
Addressing Investor Transparency, Updates from Euronet Worldwide’s (EEFT) First Analyst Day in a Decade
📈 Markets & Finance
MGM Resorts stock jumps as Barry Diller's People Inc. makes bid to take over the company
